OVERSEA CHINESE BANKING Corp Ltd Invests $337,000 in CME Group Inc. (NASDAQ:CME)

OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 1,526 shares of the financial services provider’s stock, valued at approximately $337,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Y.D. More Investments Ltd acquired a new position in CME Group in the second quarter valued at $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the period. McClarren Financial Advisors Inc. grew its stake in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC increased its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the period. Finally, New Covenant Trust Company N.A. purchased a new stake in CME Group in the first quarter valued at approximately $82,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on CME shares. Citigroup lifted their target price on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Barclays lifted their price objective on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. The Goldman Sachs Group raised their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research note on Tuesday, October 8th. Finally, Piper Sandler lifted their target price on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $224.47.

Insider Buying and Selling

In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the company’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock worth $3,441,063 in the last quarter. Company insiders own 0.30% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $228.14 on Thursday. The business has a fifty day moving average of $222.20 and a two-hundred day moving average of $210.04. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $82.15 billion, a P/E ratio of 23.99, a price-to-earnings-growth ratio of 5.69 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the business earned $2.25 earnings per share. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. As a group, analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.